Skip to main content

Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

allopurinol

A structural isomer of hypoxanthine. Allopurinol inhibits xanthine oxidase, an enzyme that converts oxypurines to uric acid. By blocking the production of uric acid, this agent decreases serum and urine concentrations of uric acid, thereby providing protection against uric acid-mediated end organ damage in conditions associated with excessive production of uric acid, i.e. the massive cell lysis associated with the treatment of some malignancies.

Check for active clinical trials using this agent View this agent in the NCI Thesaurus

Synonym:	zurinol
US brand name:	Lopurin
Foreign brand name:	Sigapurol
Abbreviation:	4'-HPP
Chemical structure:	1,5-dihydro-4H-pyrazolo[3,4-d]pryimidin-4-one 1H-pyrazolo[3,4-d]pyrimidin-4-ol 4-hydroxypyrazolo[3,4-d]pyrimidine

allopurinol

Search NCI's Drug Dictionary